GenRx Midazolam midazolam 15mg/3mL solution for injection ampoule

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

midazolam, Quantity: 15 mg

Beschikbaar vanaf:

Arrotex Pharmaceuticals Pty Ltd

INN (Algemene Internationale Benaming):

Midazolam

farmaceutische vorm:

Injection, solution

Samenstelling:

Excipient Ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide

Toedieningsweg:

Intravenous, Intramuscular

Eenheden in pakket:

5 ampoules

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

IV as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic. IV for induction of anaesthesia, preliminary to administration of other anaesthetic agents. With the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. IV for sedation in intensive care units; intermittent administration or continuous infusion. IM for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Product samenvatting:

Visual Identification: A clear colourless to pale yellow solution.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2014-10-30